Barclays analyst Gaurav Jain maintained a Buy rating on Philip Morris (PM – Research Report) today and set a price target of $145.00. The ...

The Food and Drug Administration on Thursday authorized the popular Zyn nicotine pouches for sale in the U.S., after studies by the agency determined Philip Morris International’s nicotine ...

Shares of Philip Morris International edged 0.4% higher in premarket action on Thursday to $120.80 vs. the 52-week range of $87.82 to $134.15. The dividend yield for new buyers of the stock is 4. ...

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...